Abstract
We have developed a magnetic resonance imaging (MRI) method for improved detection of cancer with a new class of cancer-specific contrast agents, containing vanadyl (VO2+)-chelated organic ligands, specifically bis(acetylacetonato)oxovanadium(IV) [VO(acac)2]. Vanadyl compounds have been found to accumulate within cells, where they interact with intracellular glycolytic enzymes. Aggressive cancers are metabolically active and highly glycolytic; an MRI contrast agent that enters cells with high glycolytic activity could provide high-resolution functional images of tumor boundaries and internal structure, which cannot be achieved by conventional contrast agents. The present work demonstrates properties of VO(acac)2 that may give it excellent specificity for cancer detection. A high dose of VO(acac)2 did not cause any acute or short-term adverse reactions in murine subjects. Calorimetry and spectrofluorometric methods demonstrate that VO(acac)2 is a blood pool agent that binds to serum albumin with a dissociation constant K d ~ 2.5 ± 0.7 × 10−7 M and a binding stoichiometry n = 1.03 ± 0.04. Owing to its prolonged blood half-life and selective leakage from hyperpermeable tumor vasculature, a low dose of VO(acac)2 (0.15 mmol/kg) selectively enhanced in vivo magnetic resonance images of tumors, providing high-resolution images of their interior structure. The kinetics of uptake and washout are consistent with the hypothesis that VO(acac)2 preferentially accumulates in cancer cells. Although VO(acac)2 has a lower relaxivity than gadolinium-based MRI contrast agents, its specificity for highly glycolytic cells may lead to an innovative approach to cancer detection since it has the potential to produce MRI contrast agents that are nontoxic and highly sensitive to cancer metabolism.
Similar content being viewed by others
Abbreviations
- AA:
-
Atomic absorption
- BSA:
-
Bovine serum albumin
- ENDOR:
-
Electron nuclear double resonance
- EPR:
-
Electron paramagnetic resonance
- EPSI:
-
Echo planar spectroscopic imaging
- HEPES:
-
N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid), sodium salt
- ITC:
-
Isothermal titration calorimetry
- MRI:
-
Magnetic resonance imaging
- PET:
-
Positron emission tomography
- VC:
-
Vanadyl chelate
- VO(acac)2 :
-
Bis(acetylacetonato)oxovanadium(IV)
References
Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KCP (1998) Nat Med 4:623–626
Kopelman R, Koo YE, Philbert M, Moffat BA, Reddy GR, McConville P, Hall DE, Chenevert TL, Bhojani MS, Buck SM, Rehemtulla A, Ross BD (2005) J Magn Magn Mater 293:404–410
Konda SD, Aref M, Wang S, Brechbiel M, Wiener EC (2001) Magn Reson Mater Phys Biol Med 12:104–113
Warburg O (1931) In: Smith RR (ed), 1st edn. New York, pp 129–169
Warburg O (1956) Science 123:309–314
Pauwels EK, Sturm EJ, Bomardieri E, Cleton FJ, Stokkel MP (2000) J Cancer Res Clin Oncol 126:549–559
Barrington SF, O’Doherty MJ (2003) Eur J Nucl Med Mol Imaging 30:S117–S127
Rajendran JG, Mankoff DA, O’Sullivan F, Peterson LM, Schwartz DL, Conrad EU, Spencer AM, Muzi M, Farwell DG, Krohn KA (2004) Clin Cancer Res 10:2245–2252
Stokkel MPM, ten Broek FW, van Rijk PP (1998) Oral Oncol 34:466–471
Gambhir SS (2002) Nat Rev Cancer 2:683–693
Strauss LG (1996) Eur J Nucl Med 23:1409–1415
Wong KP, Feng D, Meikle SR, Fulham MJ (2002) IEEE Trans Nucl Sci 49:200–207
Lee J, Burdette JE, MacRenaris KW, Mustafi D, Woodruff TK, Meade TJ (2007) Chem Biol 14:824–834
Fugono J, Yasui H, Sakurai H (2001) J Pharm Pharmacol 53:1247–1255
Nakai M, Watanabe H, Fujiwara C, Kakegawa H, Satoh T, Takada J, Matsushita R, Sakurai H (1995) Biol Pharm Bull 18:719–725
Makinen MW, Brady MJ (2002) J Biol Chem 277:12215–12220
Li J, Elberg G, Crans DC, Shechter Y (1996) Biochemistry 35:8314–8318
Caravan P, Gelmini L, Glover N, Herring FG, Li H, McNeil JH, Rettig SJ, Setyawati IA, Shuter E, Sun Y, Tracey AS, Yuen VG, Orvig C (1995) J Am Chem Soc 117:12759–12770
Sakurai H, Sano H, Takino T, Yasui H (2000) J Inorg Biochem 80:99–105
Reul BA, Amin SS, Buchet JP, Ongemba LN, Crans DC, Brichard SM (1999) Br J Pharm 126:467–477
Yuen VG, Orvig C, McNeil JH (1995) Can J Physiol Pharm 73:55–64
Pandey SK, Anand-Srivastave MB, Srivastava AK (1998) Biochemistry 37:7006–7014
Pandey SK, Theberge J-F, Bernier M, Srivastava AK (1999) Biochemistry 38:14667–14675
Mustafi D, Liszewski W, Mustafi R, Peng B, Bissonnette M, Foxley S, Karczmar GS, Ejnik JW, Martin H (2009) Mol Imaging (in press)
Chasteen ND (1981) In: Berliner LJ, Reuben J (eds) Biological magnetic resonance, vol 3. Plenum, New York, pp 53–119
Ballhausen CJ, Gray HB (1962) Inorg Chem 1:111–122
Chasteen ND, Lord EM, Thompson HJ, Grady JK (1986) Biochim Biophys Acta 884:84–92
Chasteen ND, Francavilla J (1976) J Phys Chem 80:867–871
Chasteen ND (1977) Coord Chem Rev 22:1–36
Gerfen GJ, Hanna PM, Chasteen ND, Singel DJ (1991) J Am Chem Soc 113:9513–9519
Mustafi D, Nakagawa Y (1994) Proc Natl Acad Sci USA 91:11323–11327
Mustafi D, Nakagawa Y (1996) Biochemistry 35:14703–14709
Mustafi D, Bekesi A, Vertessy BG, Makinen MW (2003) Proc Natl Acad Sci 100:5670–5675
Chen JW, Belford RL, Clarkson RB (1998) J Phys Chem A 102:2117–2130
Holko P, Ligęza J, Kisielewska J, Kordowiak AM, Klein A (2008) Pol J Pathol 59:3–8
Clarke MJ, Zhu F, Frasca DR (1999) Chem Rev 99:2511–2534
Cruz TF, Morgan A, Min W (1995) Mol Cell Biochem 153:161–166
Jackson JK, Min W, Cruz TF, Cindric S, Arsenault L, Von Hoff DD, Degan D, Hunter WL, Burt HM (1997) Br J Cancer 75:1014–1020
Fu Y, Wang Q, Yang XG, Yang XD, Wang K (2008) J Biol Inorg Chem 13:1001–1009
Scatchard G (1949) Ann N Y Acad Sci 51:660–672
Ninfa AJ, Ballou DP (1998) Fundamental laboratory approaches for biochemistry and biotechnology. Fitzgerald Science Press, Bethesda, pp 247–271
Golczak M, Maeda A, Bereta G, Maeda T, Kiser PD, Hunzelmann S, von Lintig J, Blaner WS, Palczewski K (2008) J Biol Chem 283:9543–9544
Solomaha E, Palfrey C (2005) Biochem J 391:601–611
Nelson DL, Cox MM (2005) Lehninger principles of biochemistry. Freeman, New York
Mansfield P (1984) Magn Reson Med 1:370–386
Foxley S, Fan X, Mustafi D, Yang C, Zamora M, Medved M, Karczmar GS (2008) Phys Med Biol 53:4509–4522
Foxley S, Fan X, Mustafi D, Haney C, Zamora M, Markiewicz E, Medved M, Wood AM, Karczmar GS (2009) Magn Reson Med 61:291–298
Nichols JB (2003) University Veterinarian, Florida Atlantic University. For mice: http://www.fauvet.fau.edu/oacm/VetData/Handouts/mouseHO.htm, for rat: http://www.fauvet.fau.edu/oacm/VetData/Handouts/ratHO.htm. Accessed 30 May 2003
Yang XG, Yang XD, Yuan L, Wang K, Crans DC (2004) Pharm Res 21:1026–1033
Barceloux DG (1999) Clin Toxicol 37:265–278
Fawcett JP, Farquhar SJ, Thou T, Shand BI (1997) Pharmacol Toxicol 80:202–206
McNeill JH (2000) Mol Cell Biochem 208:167–168
Mustafi D, Makinen MW (2005) Inorg Chem 44:5580–5590
Ou H, Yan L, Mustafi D, Makinen MW, Brady MJ (2005) J Biol Inorg Chem 10:874–886
Feng D, Nagy JA, Dvorak AM, Dvorak HF (2000) Microvascular Res 59:24–37
Heinemann G, Fichtl B, Mentler M, Vogt W (2002) J Inorg Biochem 90:38–42
Purcell M, Neault JF, Malonga H, Arakawa H, Tajmir-Riahi HA (2001) Can J Chem 79:1415–1421
Lakowicz J (1999) Principles of fluorescence spectroscopy. Plenum Press, New York
Freire E, Obdulio ML, Straume M (1990) Anal Biochem 62:950A–960A
Kuperman VY, River JN, Lewis MZ, Lubich LM, Karczmar GS (1995) Magn Reson Med 33:318–325
Kuperman VY, Karczmar GS, Blomley MJK, Lewis MZ, Lubich LM, Lipton MJ (1996) J Magn Reson Imaging 6:764–768
Kuperman VY, Alley MT (1999) J Magn Reson Imaging 9:172–176
Solomon GJ, Wu E, Rosen PP (2007) Arch Pathol Lab Med 131:145–148
Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA (2007) AJR Am J Roentgenol 188:586–592
Kuo PH (2008) J Am Coll Radiol 5:29–35
Dai S, McNeill JH (1994) Pharmacol Toxicol 74:110–115
Dai S, Thmpson KH, McNeill JH (1994) Pharmacol Toxicol 74:101–109
Dai S, Thompson KH, Vera E, McNeill JH (1995) Pharmacol Toxicol 75:265–273
Mukherjee B (2004) Toxicol Lett 150:135–143
Aime S, Chiaussa M, Digilio G, Gianolio E, Terreno E (1999) J Biol Inorg Chem 4:766–774
Acknowledgments
This work was supported by grants from the American Cancer Society, Illinois Division (nos. 06-18, 08-45). This work was also partially supported by grants from the National Institutes of Health (RO1 EB003108), the University of Chicago Cancer Research Center, and the Lynn S. Florsheim MRIS facility.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mustafi, D., Peng, B., Foxley, S. et al. New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer. J Biol Inorg Chem 14, 1187–1197 (2009). https://doi.org/10.1007/s00775-009-0562-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-009-0562-0